Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Nonparametric Estimation from Incomplete Observations
1958 • 37,219 citations
Cancer principles and practice of oncology
1997 • 659 citations
Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.
1994 • 349 citations
Treatment of Patients with Cancer of an Unknown Primary Site
1993 • 245 citations
Advanced Poorly Differentiated Carcinoma of Unknown Primary Site: Recognition of a Treatable Syndrome
1986 • 182 citations
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
1997 • 138 citations
Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience.
1992 • 134 citations
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
1997 • 77 citations
Carcinoma of unknown primary: Identification of a treatable subset?
1990 • 68 citations
Cited By (0)
No citing papers found in database